期刊文献+

Ⅰ_A期乳腺癌妇女的临床病理特征与生存状况研究 被引量:4

Clinicopathological Characteristics and Survival of Women with Stage Ⅰ_A Breast Cancer
下载PDF
导出
摘要 目的研究Ⅰ_A期乳腺癌妇女的临床病理特征与生存状况。方法回顾性分析138例Ⅰ_A期乳腺癌患者临床资料,采用统计学分析方法对所有患者临床资料进行统计分析。结果术后对所有患者进行中位随访,5年PFS为94.2%,5年OS为98.9%。138例患者中12例发生复发或转移。T1b期复发或转移3例,T1c期复发或转移9例。138例患者生存状况单因素分析结果显示:Ki-67表达、不同的手术方式、放疗手段和组织学分级与患者PFS相关(P<0.05),患者年龄、临床分期及曲妥珠单抗的使用与否对PFS无明显影响。Ki-67表达和组织学分级是影响患者PFS独立预后因素(P<0.05),且组织学分级中低级患者的PFS优于组织学分级高级患者,Ki-67表达<14%优于Ki-67表达≥14%者。结论Ⅰ_A期乳腺癌患者总的术后生存状况较好,对于某些亚组患者存在一定的复发率和转移率,且风险较大。 Objective To study the clinicopathological features and survival of women with stage ⅠAbreast cancer.Methods The clinical data of 138 patients with stage ⅠAbreast cancer were retrospectively analyzed. The clinical data of all patients were analyzed by statistical analysis. Results All patients were followed up,5-year PFS was 94. 2% and 5-year OS was98. 9%. 138 patients had recurrence or metastasis in 12 cases. T1 brecurrence or metastasis occurred in 3 cases,T1 crecurrence or metastasis in 9 cases. Single factor survival analysis showed that Ki-67 expression and different surgical procedures,radiotherapy and the histological grading were related with PFS( P〈0. 05),age,clinical stage and trastuzumab has no evident effect on PFS.The expression of Ki-67 and grade were independent prognostic groups factors for PFS( P〈0. 05),and patients with lower histological grade had higher PFS than patients with higher histological grade,the expression of Ki-67 〈14% is better than Ki-67 expression more than 14% people. Conclusion The overall survival rate of patients with stage ⅠAbreast cancer is good,and there is a certain recurrence rate and metastasis rate in some subgroups,and the risk is higher.
作者 张振 冯云 李振宇 曹效忠 任莎莎 ZHANG Zhen;FENG Yun;LI Zhenyu(Luoyang Central Hospital Affiliated to Zhenghzou Universtity,Luoyang,471000)
出处 《实用癌症杂志》 2018年第9期1516-1518,共3页 The Practical Journal of Cancer
关键词 ⅠA期 乳腺癌 临床病理特征 生存状况 Stage ⅠA Breast cancer Pathological characteristics Survival
  • 相关文献

参考文献10

二级参考文献141

  • 1须捷平,徐曙光,张云,俞羚,吴连明,殷志强,曹晖.三阴性乳腺癌的临床病理特征和预后影响因素分析[J].上海交通大学学报(医学版),2011,31(5):637-641. 被引量:18
  • 2马静,魏素菊,王俊艳,刘巍,刘风铃,姜达.BRCA1、TopoⅡα、Bcl-2在三阴乳腺癌中的表达及对预后的影响[J].中国老年学杂志,2014,34(7):1811-1813. 被引量:6
  • 3安松林,方志沂,于泳.青年乳腺癌的临床特点及预后[J].实用癌症杂志,2005,20(6):639-642. 被引量:14
  • 4邬玉辉,何英,唐利立.青年期女性乳腺癌临床病理分析[J].实用预防医学,2006,13(3):545-547. 被引量:8
  • 5BESLIJA S, BONNETERRE J, BURSTEIN H. Third consensus on medical treatment of metastatic breast cancer[J]. Ann Oncol, 2009, 20(11 ):1771-1785.
  • 6DIAZ-CANTON E A, VALERO V, RAHMAN Z, et al. Clinical course of breast cancer patients with metastases confined to the lungs treated with chemotherapy. The University of Texas M.D. Anderson Cancer Center experience and review of the literature[J]. Ann Oncol, 1998, 9(4):413-41 8.
  • 7LEE Y T. Breast carcinoma: pattern of metastasis at autopsy[J].J Surg Oncol, 1983, 23(3):1 75-180.
  • 8TAMIMI R M, COLDITZ G A, HAZRA A, et al. Traditional breast cancer risk factors in relation to molecular subtypes of breast cancer[J]. Breast Cancer Res Treat, 1 31 (1): 1 5 9-1 6 7.
  • 9EARLY BREAST CANCER TRIALISTS'COLLABORATIVE GROUP (EBCTCG). Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials [J]. Lancet, 2005, 365(9472): 1687-1717.
  • 10INGLE J N. Principles of treatment in advanced breast cancer[J]. HematolOncol Clin North Am, 1 989, 3(4):743-763.

共引文献103

同被引文献56

引证文献4

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部